Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Ранг среди акций #26668
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Цена акции
$5.54
Последняя синхронизация: 2024-09-18
Рыночная капитализация
$38.76M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Alimera Sciences, Inc. (ALIM)

Категория

EPS для Alimera Sciences, Inc. (ALIM)
EPS по состоянию на June 2024 TTM: $-0.28
Согласно последним финансовым отчетам и цене акций Alimera Sciences, Inc., текущий EPS компании (TTM) составляет $-0.28. В конце 2022 EPS компании составлял $-2.59, больше, чем показателю 2021 года, равному $-0.66.
История EPS компании Alimera Sciences, Inc. с 2006 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-0.28 -64.56%
2023 $-0.79 -69.50%
2022 $-2.59 292.42%
2021 $-0.66 -36.54%
2020 $-1.04 -52.51%
2019 $-2.19 -158.40%
2018 $3.75 -176.06%
2017 $-4.93 -47.66%
2016 $-9.42 -8.90%
2015 $-10.34 -22.43%
2014 $-13.33 -45.14%
2013 $-24.30 158.24%
2012 $-9.41 -12.63%
2011 $-10.77 61.95%
2010 $-6.65 -98.48%
2009 $-437.12 -23.24%
2008 $-569.46 977.30%
2007 $-52.86 -56.02%
2006 $-120.18 0.00%
EPS для аналогичных компаний или конкурентов